Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
Our high-tech, dedicated method is applied to construct targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
This approach involves comprehensive molecular simulations of the catalytic and allosteric binding pockets and ensemble virtual screening that accounts for their conformational flexibility. In the case of designing modulators, the structural adjustments caused by reaction intermediates are considered to improve activity and selectivity.
Key features that set our library apart include:
partner
Reaxense
upacc
Q8IXK2
UPID:
GLT12_HUMAN
Alternative names:
Polypeptide GalNAc transferase 12; Protein-UDP acetylgalactosaminyltransferase 12; UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 12
Alternative UPACC:
Q8IXK2; Q5TCF7; Q8NG54; Q96CT9; Q9H771
Background:
Polypeptide N-acetylgalactosaminyltransferase 12, also known as GALNT12, plays a pivotal role in the biosynthesis of mucin-type oligosaccharides in digestive organs. It catalyzes the transfer of N-acetyl-D-galactosamine to serine or threonine residues on protein receptors, crucial for the initial step of mucin-type oligosaccharide biosynthesis. GALNT12 shows specificity towards non-glycosylated peptides, indicating its selective role in cellular processes.
Therapeutic significance:
GALNT12's involvement in colorectal cancer underscores its potential as a therapeutic target. Although its role in cancer susceptibility is debated, understanding GALNT12's function could lead to novel strategies for colorectal cancer prevention and treatment, highlighting the importance of further research in this area.